Martina Bernardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martina Bernardi has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Catanzaro
Haematology Unit, Laboratory of Advanced Cellular Therapies, San Bortolo Hospital, Vicenza, Italy
2 shared publications - Giuseppe Astori
Advanced Cellular Therapy Laboratory, Hematology Unit, Vicenza Hospital, Vicenza, Italy
2 shared publications A. Boni
Inserm U1138, Université Paris Descartes, Université Pierre Et Marie Curie, Paris/FR
1 shared publication- Angela Bozza
Advanced Cellular Therapy Laboratory, Haematology Unit, San Bortolo Hospital, Vicenza, Italy
1 shared publication Anna Merlo
Haematology Unit, Laboratory of Advanced Cellular Therapies, San Bortolo Hospital, Vicenza, Italy
1 shared publication- Anna Merlo
Advanced Cellular Therapy Laboratory, Haematology Unit, San Bortolo Hospital, Vicenza, Italy
1 shared publication
Latest Publications
- Open Access
- 8 April 2025
- Published by Elsevier in Cytotherapy
- Vol. 27 (9) , 1105-1115
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial
- 8 April 2025
- Published by Elsevier in Cytotherapy
- Vol. 27 (9) , 1105-1115
Open AccessImpact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial
- Open Access
- 1 March 2023
- Published by Taylor & Francis in Hematology
- Vol. 28 (1) , 2182056
Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera
Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery ...
- 1 March 2023
- Published by Taylor & Francis in Hematology
- Vol. 28 (1) , 2182056
Open AccessEnalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera
Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery ...
- 1 October 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (10) , S550
P1.09-02 PD-L1 Expression Pattern in Large Cell Neuroendocrine Carcinoma of the Lung: The GFPC 03-2017 "EPNEC" Study
- 1 October 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (10) , S550
P1.09-02 PD-L1 Expression Pattern in Large Cell Neuroendocrine Carcinoma of the Lung: The GFPC 03-2017 "EPNEC" Study
- Open Access
- 1 April 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 58, S238
580 POST-TRANSCRIPTIONAL CHANGES OF SERUM ALBUMIN ARE ASSOCIATED WITH CLINICAL FEATURES AND POOR SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS
- 1 April 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 58, S238
Open Access580 POST-TRANSCRIPTIONAL CHANGES OF SERUM ALBUMIN ARE ASSOCIATED WITH CLINICAL FEATURES AND POOR SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS